… compared with 22 percent of the fake gel group. The hormone group also reported having more energy. “The overall health benefits, however, remain to be determined,” the researchers said. The studies were published Tuesday in the Journal of the …
Category: Anemia
Folate Market Value Share, Analysis and Segments 2016-2026
… Prices are beginning to climb down as a consequence of new starts. Folate Market: Drivers & Restraints Increased health awareness among consumer, is driving them for the consumption of folate based products. Another key driver for the folate market …
Ferrous Sulfate Market Forecast and Value by End-Use Industry 2016-2026
Ferrous Sulfate: Industry Analysis The ferrous sulfate , also known as the Green Vetriol or Copperas since the middle ages, essentially provides iron needed by the body. The ferrous sulfate market is booming in places where the population is high and is growing quickly, for instance China, India and U.S.A. Asia is a major stakeholder in the ferrous sulfate market and produces roughly around 80% of ferrous sulfate produced in the world.
Akebia sells rights to anemia drug to Japan’s Otsuka
Drug developer Akebia Therapeutics Inc said on Tuesday it had signed a co-development and marketing deal worth up to $1 billion with Japan’s Otsuka Holdings Co Ltd. Akebia said the deal would give it the funds needed to develop vadadustat, its experimental drug to treat anemia associated with chronic kidney disease. Akebia’s shares were up 17.1 percent at $9.78 in early trading.